[Elsevier] Pembrolizumab lenvatinib in metastatic uterine carcinosarcoma cohort: safety and efficacy from the french multicenter early access program subgroup (LARENA study) |
|
This post will be closed automatically in 2026-10-21 06:39
Reward10points
|
10
What did we learn from the North American Income Maintenance Experiments? New data and evidence on two-parent families
10
Who considers, who owns? Multi-study evidence on the behavioral process of cryptocurrency adoption in the United States
10
AI-chatbots＊ positive emotional expression may backfire: A perspective of emotional intensity
10
More flexible or more rigid? A study on the double-edged sword effect of Gen AI usage dependence on employees＊ emotional labor
10
The relative impact of innate skills and acquired attributes on stock market participation
